How to Perform an ADCC Assay: Step-by-Step Protocol

At Liv Hospital, we start with precision at the cellular level. Our team works on treatments that boost the body’s defenses against diseases. We use the adcc assay to see how immune cells attack harmful targets.

This method is key to linking lab work to real-world success for our patients. By watching natural killer cells, we can guess how well new treatments will work. We follow a strict adcc assay protocol to make sure our results are right and reliable.

We’re committed to using the latest research to help you get better. Our experts think standardized testing is vital for creating life-saving treatments. This dedication helps us offer top-notch care in a caring and professional setting.

Key Takeaways

• Quantifies the destruction of target cells by immune effector cells.
• Functions as a critical link between drug design and patient outcomes.
• Focuses on the activity of natural killer cells against coated targets.
• Provides essential data for researchers developing new monoclonal therapies.
• Ensures reliable results through standardized and up-to-date methodologies.
• Reflects a commitment to academic precision and compassionate clinical care.

Understanding ADCC Mechanism and Applications

It’s important for researchers to understand ADCC to develop new treatments and study the immune system. The ADCC assay protocol is key for this. It helps measure how well antibodies work in fighting diseases.

The Three-Step ADCC Process

The ADCC process has a three-step mechanism. First, antibodies attach to target cells. Then, effector cells find these cells through their Fc receptors. Lastly, the effector cells destroy the target cells by releasing granules.

This starts when antibodies bind to antigens on target cells. This marks them for destruction. Next, NK cells and PBMCs recognize these cells.

Role of Natural Killer Cells and PBMCs

Natural Killer (NK) cells are vital in ADCC. They spot antibody-coated cells and get activated. This leads to the release of granules that kill the cells.

Peripheral Blood Mononuclear Cells (PBMCs) also help in ADCC. They include different immune cells like lymphocytes and monocytes. These cells can fight ADCC in various ways.

Applications in Immunological Research

The ADCC assay is used a lot in immunology. It helps in making therapeutic antibodies. By testing how well these antibodies work, researchers can see if they’re good for treating diseases like cancer.

ADCC assays also help us understand how our immune system reacts to infections. They help in creating new treatments that use the immune system to fight diseases.

Materials and Preparation Requirements

To get a good ADCC assay, you need to know what materials and steps are needed. It’s important to pick and prepare the right parts carefully. This makes sure the assay’s results are accurate and reliable.

Setting up an ADCC assay takes several key steps. First, you need to choose and prepare the materials. These include target cells, therapeutic antibodies, effector cells, and systems for detecting results. Each part is important for the assay’s success.

Target Cells and Therapeutic Antibodies

Choosing the right target cells is key. They depend on the ADCC assay’s purpose. Common targets are NALM-6, A549, and SKBR3, used in studies on blood cancers and solid tumors. The therapeutic antibodies, like anti-CD19, anti-EGFR, and anti-HER2, are picked based on their match with the target cells and the study’s goals. Getting the right amount of therapeutic antibodies is very important for the assay’s success.

Target cells need to be grown and kept in good shape for the assay. The therapeutic antibodies also need to be properly tested to find the best concentration for the ADCC assay.

Effector Cell Selection

Effector cells, like Natural Killer (NK) cells or Peripheral Blood Mononuclear Cells (PBMCs), are key for ADCC. The choice between NK cells and PBMCs depends on the study’s needs. NK cells are great for their strong killing power, while PBMCs offer a richer view of the immune system.

When picking effector cells, think about their readiness and health. Handling and preparing effector cells right is key for getting good and consistent results in the ADCC assay.

Detection Systems

Detection systems in ADCC assays measure how well effector cells kill target cells. Methods like using Annexin V or TMRE (Tetramethylrhodamine, ethyl ester) check cell health and death. The right detection system depends on the assay’s needs and how sensitive it needs to be.

Each detection method has its own strengths and weaknesses. For example, Annexin V is good for spotting early cell death, while TMRE shows cell health by checking mitochondrial function. Picking the right detection system is critical for measuring ADCC correctly.

By carefully choosing materials and preparation steps, researchers can make sure their ADCC assays work well. This means picking the best target cells, therapeutic antibodies, effector cells, and detection systems. It also means making sure they are all prepared and handled correctly.

Complete ADCC Assay Protocol with Detailed Instructions

To conduct an ADCC assay, researchers must follow a detailed protocol. This guide will help you through each step, ensuring accurate results.

Step 1: Target Cell Preparation and Seeding

The first step is preparing and seeding target cells. Target cells are usually tumor cells or cells with the antigen of interest. We start by culturing these cells in the right medium, making sure they’re healthy and growing well.

Then, we seed the cells in a 96-well plate. The number of cells per well varies, depending on the cell type and assay needs. It’s usually between 5,000 to 10,000 cells per well.

Step 2: Effector Cell Thawing and Activation

Effector cells, like Natural Killer (NK) cells or Peripheral Blood Mononuclear Cells (PBMCs), are key in the ADCC assay. We thaw and activate these cells according to set protocols. It’s important to check their viability and function for reliable results.

Step 3: Antibody Coating of Target Cells

Therapeutic antibodies coat the target cells for the ADCC reaction. We dilute the antibodies and add them to the cells. The cells are then incubated to allow the antibodies to bind to the antigens.

Step 4: Adding Effector Cells at Proper Ratios

We add effector cells to the target cells at different ratios. Ratios range from 50:1 to 1:1, based on the assay’s needs. We mix the cells gently and incubate them for a few hours to overnight.

ADCC activity can be detected through methods like flow cytometry. We use markers like Annexin V for apoptosis or TMRE for mitochondrial membrane. The choice depends on the assay’s needs and target cell characteristics.

By following this protocol, researchers can conduct ADCC assays effectively. This helps understand how therapeutic antibodies work and the immune responses they trigger.

Conclusion

Doing an ADCC assay needs careful thought about several important things. These include picking the right target cells, getting the effector cells ready, and coating the antibodies. Knowing how ADCC works and following a clear guide helps researchers get good and consistent results.

The ADCC assay is a key tool in studying the immune system. It helps check how well therapeutic antibodies work and understand how the immune system fights off diseases. It’s also important in cancer research and immunotherapy, leading to new treatments.

By learning the ADCC assay well, researchers can help us understand the immune system better. This knowledge helps in making new treatments. The findings from ADCC assays will keep guiding the field of immunology, helping to make better treatments and improve health outcomes.

FAQ

 References

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31263507/